DrShahidaDin
@ShahidaDin1
Followers
2K
Following
14K
Media
526
Statuses
4K
Gastroenterologist. IBD Researcher. Chair of the 🇬🇧 Society of Gastroenterology Inflammatory Bowel Disease (IBD) Committee @[email protected]
Edinburgh, Scotland
Joined February 2019
Several stakeholders have advocated for minimising placebo controlled RCTs. We analysed the harms [Adverse Events,[AEs]] associated with placebo in inflammatory bowel diseases (IBD) RCTs. @alex_ford12399 @Bealoquebea @Jonathansegal85 @JonnyBlackwell @DrCJBlack @GastroRes_Leeds
7
56
120
A rare vomiting condition associated with chronic cannabis use is becoming more common at ER's in the U.S. The condition, cannabinoid hyperemesis syndrome (CHS), is marked by severe and cyclical bouts of uncontrollable nausea, abdominal pain & vomiting https://t.co/2fHQ30N8xZ
sciencealert.com
Why is it happening?
6
12
27
Went to the 1st IBD focused endoscopy training day ever in >20 years of IBD practice! Hosted by St George’s Hospital @Sash_Honap @Kesavan_Kandiah @VCsurgery @SGH_IBD Prototype for refinement & wider dissemination @BritSocGastro @JAG_Endoscopy 🙌🏽🤗
0
3
7
We are a step closer to building personalised treatment pathways based on who is more likely to benefit from specific therapies. @qianzhang314 @IBD_BioResource
https://t.co/ot9FkYyJlt
academic.oup.com
AbstractBackground and Aims. Loss of response (LoR) is a major limitation of anti-TNF therapy in inflammatory bowel disease (IBD). It can result from immun
2
2
10
❤️ ❤️ ❤️ - thank you @JonnyBlackwell - you are one of our favourites too!
I’m delighted to have been a small cog in this massively important work led by Dr Amirhosein Kefayat & @ShahidaDin1 I’m also incredibly chuffed it’s been published in my favourite journal @FrontGastro_BMJ 😉 😀
0
1
6
Another great paper published in @FrontGastro_BMJ - thank you to @ahkefayat @EdinUni_IGC @ross_j_porter @amd_churchhouse @JonnyBlackwell @drmorrisgordon @drgauravbnigam @ProfChrisLamb @alex_ford12399 and @ShahidaDin1 #IBD #Chemoprevention @Gut_BMJ @BMJOpen_Gastro
📣chemoprevention in inflammatory bowel disease. In the absence of RCT data➡️50 observational studies: 1.4 million patients: Anti-TNFs⬇️colorectal cancer (CRC) risk in ulcerative colitis (UC) & 5-ASAs⬇️CRC risk in UC and Crohn’s disease 👇🏽@ahkefayat @EdinUni_IGC 🙏🏽to all authors
0
4
10
I’m delighted to have been a small cog in this massively important work led by Dr Amirhosein Kefayat & @ShahidaDin1 I’m also incredibly chuffed it’s been published in my favourite journal @FrontGastro_BMJ 😉 😀
📣chemoprevention in inflammatory bowel disease. In the absence of RCT data➡️50 observational studies: 1.4 million patients: Anti-TNFs⬇️colorectal cancer (CRC) risk in ulcerative colitis (UC) & 5-ASAs⬇️CRC risk in UC and Crohn’s disease 👇🏽@ahkefayat @EdinUni_IGC 🙏🏽to all authors
1
5
10
What effect do 5-ASA and anti-TNF drugs have on the risk of developing colorectal cancer in #IBD? We'll be discussing this (and more) from a patient perspective in an upcoming podcast episode. https://t.co/uA3CHSM586
fg.bmj.com
Objective The incidence of colorectal cancer (CRC) remains elevated in the inflammatory bowel disease (IBD) population. We aimed to examine the association of biologics, 5-aminosalicylates (5-ASAs)...
2
7
25
A very important paper which adds to very active controversies in the #IBD family:a) thiopurines loosing relevance;b)5-ASA is has very likely a chemoprotective role, not only in #UC;c)antiTNF effective and less inflammation means less oncogenesis.Tx decisions have many sides 👇👇
📣chemoprevention in inflammatory bowel disease. In the absence of RCT data➡️50 observational studies: 1.4 million patients: Anti-TNFs⬇️colorectal cancer (CRC) risk in ulcerative colitis (UC) & 5-ASAs⬇️CRC risk in UC and Crohn’s disease 👇🏽@ahkefayat @EdinUni_IGC 🙏🏽to all authors
1
4
12
Delighted to have been asked to write this article by @PhilSmithIsBack for @FrontGastro_BMJ Hopefully useful for residents and some familiar themes for career academics. Reflecting on a career as a clinical academic in gastroenterology
fg.bmj.com
At the end of 2026, I will have been a clinical academic in gastroenterology for 25 years. I have enjoyed my time, so far, thoroughly, but it has been hard work, and I have had to make some sacrifi...
3
23
42
📣chemoprevention in inflammatory bowel disease. In the absence of RCT data➡️50 observational studies: 1.4 million patients: Anti-TNFs⬇️colorectal cancer (CRC) risk in ulcerative colitis (UC) & 5-ASAs⬇️CRC risk in UC and Crohn’s disease 👇🏽@ahkefayat @EdinUni_IGC 🙏🏽to all authors
6
23
55
0
2
3
Congratulations to two well known researchers in the field of luminal gastroenterology for being awarded the UEG Rising Star Awards 2026. Best wishes from the BSG community for your well deserved honour. @BritSocGastro
2
2
16
🎄🎄🎄For the 12 Days of Christmas... On the second day of Christmas, we have an amazing array of world-class speakers including Dr. D. Nageshwar Reddy who is giving the Christopher Williams Lecture at #EndoBridge 2026 Early bird tickets close on Dec 12th so don't miss out 🧑🎄
0
2
4
🎄🎄🎄For the 12 Days of Christmas... On the first day of Christmas, we are kicking off with live #endoscopy from India and Leeds! Early bird tickets close on Dec 12th so don't miss out 🧑🎄on #EndoBridge 2026
0
3
7
📢 Applications for the 2026-2027 Morris Fishbein Fellowship in Medical Editing are due January 5. This one-year fellowship at JAMA’s Chicago headquarters offers physicians hands-on experience in editing and publishing a leading medical journal. Apply now:
0
3
17
@researchactive emphasizes the importance of open conversations in improving IBD care. We are really grateful for your contribution to today’s IBD Day at #ECCStGallen2025.
1
4
4
Join us at IBD360 on 19 – 20 January 2026 in Birmingham and hear the latest in clinical #IBD practice and research! 🙌 Check out our exciting highlight sessions in the two-day programme, secure your place here 👉 https://t.co/mzfxff4xrR
0
3
5
Grateful for the opportunity to contribute to this bit of work led by some of the superstars of #IBD @vipuljairath et al Recommendations to Standardize the Conduct of Clinical Trials Evaluati...
1
1
12
https://t.co/I6wBlGMKRs Mission: Intestinal Ultrasound (IUS)- And the ‘Probe’ Begins THE pIBD DIGEST launches its two-part Mission: IUS special!! In this episode, hosts Dr Tracy Coelho and Dr Chris Bakewell team up with an expert squad: Dr Richard Jenkins ( paediatric
open.spotify.com
THE pIBD DIGEST · Episode
1
4
7
⏰ Last chance to apply for an Undergraduate Elective Bursary, closing TOMORROW at 5pm! Don’t miss out on up to £500 to support your elective in #Gastroenterology or #Hepatology, covering travel, accommodation & more. Apply now 👉 https://t.co/kyCbCprz4b
@BSGTrainees
0
2
5